Sign up to save your podcasts
Or
Share Immunotherapy Keytruda for Early-Stage Triple-Negative Breast Cancer: Better pCR and Lower Recurrence Rates: ESMO 2019 Coverage
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Immunotherapy Keytruda for Early-Stage Triple-Negative Breast Cancer: Better pCR and Lower Recurrence Rates: ESMO 2019 Coverage
Dr. Peter Schmid is chair in cancer medicine at Barts Cancer Institute, Queen Mary University London and also serves as clinical director of the Breast Cancer Centre at the St. Bartholomew Cancer Centre and honorary consultant medical oncologist at Barts Hospital. His research focuses on breast cancer, cancer immune therapy, and early drug development.
At the European Society for Medical Oncology 2019 Congress, he presented results from the KEYNOTE-522 study showing that the combination of the immunotherapy Keytruda (chemical name: pembrolizumab) and chemotherapy before surgery to remove early-stage triple-negative breast cancer led to a better pathologic complete response than chemotherapy alone. This is the first phase III study using immunotherapy to treat early-stage breast cancer.
Listen to the podcast to hear Dr. Schmid discuss:
View all episodes
By Breastcancer.org
4.3
4242 ratings
Dr. Peter Schmid is chair in cancer medicine at Barts Cancer Institute, Queen Mary University London and also serves as clinical director of the Breast Cancer Centre at the St. Bartholomew Cancer Centre and honorary consultant medical oncologist at Barts Hospital. His research focuses on breast cancer, cancer immune therapy, and early drug development.
At the European Society for Medical Oncology 2019 Congress, he presented results from the KEYNOTE-522 study showing that the combination of the immunotherapy Keytruda (chemical name: pembrolizumab) and chemotherapy before surgery to remove early-stage triple-negative breast cancer led to a better pathologic complete response than chemotherapy alone. This is the first phase III study using immunotherapy to treat early-stage breast cancer.
Listen to the podcast to hear Dr. Schmid discuss:
More shows like Breastcancer.org Podcast
View all
TED Radio Hour
21,967 Listeners
Well Beyond 40
1,116 Listeners
The mindbodygreen Podcast
2,034 Listeners
Dr. Berg’s Healthy Keto and Intermittent Fasting Podcast
1,691 Listeners
The Proof with Simon Hill
2,636 Listeners
Dhru Purohit Show
3,495 Listeners
The Dr. Hyman Show
9,290 Listeners
Breast Cancer Conversations
53 Listeners
Life Kit
4,488 Listeners
This Is So Awkward
328 Listeners
Dr. Streicher’s Inside Information: Menopause, Midlife, and More
388 Listeners
The Mel Robbins Podcast
20,139 Listeners
The Dr. Gabrielle Lyon Show
1,171 Listeners
Keeping Abreast with Dr. Jenn
120 Listeners
The Menopause and Cancer Podcast
30 Listeners